Comparison of outcomes between ultrasonography and cystoscopy in the surveillance of patients with initially diagnosed TaG1-2 bladder cancers: A matched-pair analysis

Naoya Niwa, Kazuhiro Matsumoto, Nozomi Hayakawa, Yujiro Ito, Takahiro Maeda, Seiya Akatsuka, Takeshi Masuda, So Nakamura, Nobuyuki Tanaka

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

PURPOSE: To examine the clinical outcomes of regular use of ultrasonography when compared with those of cystoscopy in the follow-up of patients with TaG1-2 bladder tumors.

PATIENTS AND METHODS: Between 1990 and 2012, 197 patients with TaG1-2 bladder tumors from a retrospective 2-institution cohort were included. We assessed clinical outcomes in 83 patients followed up by ultrasonography, matched for propensity score calculated from clinicopathological variables including age, gender, tumor multiplicity, size, grade, postoperative immediate chemoinstillation, and adjuvant intravesical treatment.

RESULTS: Among the 166 patients identified using the one-to-one propensity score analysis, the 5- and 10-year recurrence-free survival rates were both 63.3% in the cystoscopy group and 69.1% and 58.4%, respectively, in the ultrasonography group (P = 0.762). A total of 54 patients experienced disease recurrence, and 18 patients acquired progressive disease such as tumor grade 3, pT1 tumors, and the appearance of concurrent carcinoma in situ. There were no significant differences in the characteristics of recurrent tumors between both the groups, whereas time to first recurrence in the cystoscopy group was significantly shorter than that in the ultrasonography group (P = 0.021). In a subgroup analysis using 111 patients without adjuvant intravesical treatments, the 5- and 10-year recurrence-free survival rates were both 56.9% in the cystoscopy group and 71.9% and 60.3%, respectively, in the ultrasonography group (P = 0.282).

CONCLUSIONS: This retrospective study suggests that ultrasonography may be one of the follow-up substitutes when considering the management of low-risk bladder tumors such as TaG1-2 bladder tumors.

Original languageEnglish
JournalUrologic Oncology
Volume33
Issue number9
DOIs
Publication statusPublished - 2015 Sep 1
Externally publishedYes

Fingerprint

Matched-Pair Analysis
Cystoscopy
Urinary Bladder Neoplasms
Ultrasonography
Recurrence
Propensity Score
Neoplasms
Survival Rate
Carcinoma in Situ
Risk Management
Retrospective Studies
Therapeutics

Keywords

  • Bladder cancer
  • Cystoscopy
  • Follow-up
  • Recurrence
  • Surveillance
  • Ultrasonography

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Comparison of outcomes between ultrasonography and cystoscopy in the surveillance of patients with initially diagnosed TaG1-2 bladder cancers : A matched-pair analysis. / Niwa, Naoya; Matsumoto, Kazuhiro; Hayakawa, Nozomi; Ito, Yujiro; Maeda, Takahiro; Akatsuka, Seiya; Masuda, Takeshi; Nakamura, So; Tanaka, Nobuyuki.

In: Urologic Oncology, Vol. 33, No. 9, 01.09.2015.

Research output: Contribution to journalArticle

@article{cea63568492e414b8ca690abec82411e,
title = "Comparison of outcomes between ultrasonography and cystoscopy in the surveillance of patients with initially diagnosed TaG1-2 bladder cancers: A matched-pair analysis",
abstract = "PURPOSE: To examine the clinical outcomes of regular use of ultrasonography when compared with those of cystoscopy in the follow-up of patients with TaG1-2 bladder tumors.PATIENTS AND METHODS: Between 1990 and 2012, 197 patients with TaG1-2 bladder tumors from a retrospective 2-institution cohort were included. We assessed clinical outcomes in 83 patients followed up by ultrasonography, matched for propensity score calculated from clinicopathological variables including age, gender, tumor multiplicity, size, grade, postoperative immediate chemoinstillation, and adjuvant intravesical treatment.RESULTS: Among the 166 patients identified using the one-to-one propensity score analysis, the 5- and 10-year recurrence-free survival rates were both 63.3{\%} in the cystoscopy group and 69.1{\%} and 58.4{\%}, respectively, in the ultrasonography group (P = 0.762). A total of 54 patients experienced disease recurrence, and 18 patients acquired progressive disease such as tumor grade 3, pT1 tumors, and the appearance of concurrent carcinoma in situ. There were no significant differences in the characteristics of recurrent tumors between both the groups, whereas time to first recurrence in the cystoscopy group was significantly shorter than that in the ultrasonography group (P = 0.021). In a subgroup analysis using 111 patients without adjuvant intravesical treatments, the 5- and 10-year recurrence-free survival rates were both 56.9{\%} in the cystoscopy group and 71.9{\%} and 60.3{\%}, respectively, in the ultrasonography group (P = 0.282).CONCLUSIONS: This retrospective study suggests that ultrasonography may be one of the follow-up substitutes when considering the management of low-risk bladder tumors such as TaG1-2 bladder tumors.",
keywords = "Bladder cancer, Cystoscopy, Follow-up, Recurrence, Surveillance, Ultrasonography",
author = "Naoya Niwa and Kazuhiro Matsumoto and Nozomi Hayakawa and Yujiro Ito and Takahiro Maeda and Seiya Akatsuka and Takeshi Masuda and So Nakamura and Nobuyuki Tanaka",
year = "2015",
month = "9",
day = "1",
doi = "10.1016/j.urolonc.2015.04.018",
language = "English",
volume = "33",
journal = "Urologic Oncology",
issn = "1078-1439",
publisher = "Elsevier Inc.",
number = "9",

}

TY - JOUR

T1 - Comparison of outcomes between ultrasonography and cystoscopy in the surveillance of patients with initially diagnosed TaG1-2 bladder cancers

T2 - A matched-pair analysis

AU - Niwa, Naoya

AU - Matsumoto, Kazuhiro

AU - Hayakawa, Nozomi

AU - Ito, Yujiro

AU - Maeda, Takahiro

AU - Akatsuka, Seiya

AU - Masuda, Takeshi

AU - Nakamura, So

AU - Tanaka, Nobuyuki

PY - 2015/9/1

Y1 - 2015/9/1

N2 - PURPOSE: To examine the clinical outcomes of regular use of ultrasonography when compared with those of cystoscopy in the follow-up of patients with TaG1-2 bladder tumors.PATIENTS AND METHODS: Between 1990 and 2012, 197 patients with TaG1-2 bladder tumors from a retrospective 2-institution cohort were included. We assessed clinical outcomes in 83 patients followed up by ultrasonography, matched for propensity score calculated from clinicopathological variables including age, gender, tumor multiplicity, size, grade, postoperative immediate chemoinstillation, and adjuvant intravesical treatment.RESULTS: Among the 166 patients identified using the one-to-one propensity score analysis, the 5- and 10-year recurrence-free survival rates were both 63.3% in the cystoscopy group and 69.1% and 58.4%, respectively, in the ultrasonography group (P = 0.762). A total of 54 patients experienced disease recurrence, and 18 patients acquired progressive disease such as tumor grade 3, pT1 tumors, and the appearance of concurrent carcinoma in situ. There were no significant differences in the characteristics of recurrent tumors between both the groups, whereas time to first recurrence in the cystoscopy group was significantly shorter than that in the ultrasonography group (P = 0.021). In a subgroup analysis using 111 patients without adjuvant intravesical treatments, the 5- and 10-year recurrence-free survival rates were both 56.9% in the cystoscopy group and 71.9% and 60.3%, respectively, in the ultrasonography group (P = 0.282).CONCLUSIONS: This retrospective study suggests that ultrasonography may be one of the follow-up substitutes when considering the management of low-risk bladder tumors such as TaG1-2 bladder tumors.

AB - PURPOSE: To examine the clinical outcomes of regular use of ultrasonography when compared with those of cystoscopy in the follow-up of patients with TaG1-2 bladder tumors.PATIENTS AND METHODS: Between 1990 and 2012, 197 patients with TaG1-2 bladder tumors from a retrospective 2-institution cohort were included. We assessed clinical outcomes in 83 patients followed up by ultrasonography, matched for propensity score calculated from clinicopathological variables including age, gender, tumor multiplicity, size, grade, postoperative immediate chemoinstillation, and adjuvant intravesical treatment.RESULTS: Among the 166 patients identified using the one-to-one propensity score analysis, the 5- and 10-year recurrence-free survival rates were both 63.3% in the cystoscopy group and 69.1% and 58.4%, respectively, in the ultrasonography group (P = 0.762). A total of 54 patients experienced disease recurrence, and 18 patients acquired progressive disease such as tumor grade 3, pT1 tumors, and the appearance of concurrent carcinoma in situ. There were no significant differences in the characteristics of recurrent tumors between both the groups, whereas time to first recurrence in the cystoscopy group was significantly shorter than that in the ultrasonography group (P = 0.021). In a subgroup analysis using 111 patients without adjuvant intravesical treatments, the 5- and 10-year recurrence-free survival rates were both 56.9% in the cystoscopy group and 71.9% and 60.3%, respectively, in the ultrasonography group (P = 0.282).CONCLUSIONS: This retrospective study suggests that ultrasonography may be one of the follow-up substitutes when considering the management of low-risk bladder tumors such as TaG1-2 bladder tumors.

KW - Bladder cancer

KW - Cystoscopy

KW - Follow-up

KW - Recurrence

KW - Surveillance

KW - Ultrasonography

UR - http://www.scopus.com/inward/record.url?scp=84976600817&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84976600817&partnerID=8YFLogxK

U2 - 10.1016/j.urolonc.2015.04.018

DO - 10.1016/j.urolonc.2015.04.018

M3 - Article

C2 - 26027764

AN - SCOPUS:84940467154

VL - 33

JO - Urologic Oncology

JF - Urologic Oncology

SN - 1078-1439

IS - 9

ER -